Table 5 Extent of disease, status of disease at COVID-19 diagnosis and treatment received according to tumour diagnosis.

Diagnosis	Patients (n = 46)	Extent of disease		Status of disease at COVID-19 diagnosis			Treatment received
Diagnosis	Patients (n = 46)	Localised	Metastatic/Systemic	PD	non-PD	NED	Naive	Surgery	RT	CT	Ig	Target	Hormone
Solid tumour	33	17	16	19	10	4	15	3	4	8	2	1	4
Lung	9	2	7	6	2	1	5	1	1	1	1	0	0
GI	10	8	2	7	1	2	6	2	1^a	2^a	0	0	0
Breast	3	1	2	0	2	1	0	0	0	1	0	0	2
GU	6	3	3	4	2	0	3	0	0	1^b	1^b	1	1
Other^c	5	3	2	2	3	0	1	0	2^a	3^a	0	0	1
Haematologic	13	0	13	3	8	2	6	0	1	5	2	0	0
AML	3	0	3	3	0	0	2	0	0	1	0	0	0
MDS	4	0	4	0	4	0	3	0	0	1	0	0	0
LLC	3	0	3	0	3	0	3	0	0	0	0	0	0
LMC	1	0	1	0	0	1	0	0	0	1^a,b	1^b	0	0
NHL	2	0	2	0	1	1	0	0	1^a	2^a,b	1^b	0	0

GI gastrointestinal, GU genitourinary, AML acute myeloid leukemia, MDS myelodysplastic syndrome, CLL chronic lymphocytic leukemia, CML chronic myeloid leukemia, NHL non-Hodgkin lymphoma.
^aOne patient underwent chemo-radiation.
^bOne patient underwent immuno-chemotherapy.
^cTwo patients had head&neck cancer, one had glioblastoma, one had neuroendocrine tumour and one had unknown primary tumour.

Quick links

Search